GSK2881078
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GSK2881078, covering 2017-03-06 to 2020-07-15. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]